Multiple Sclerosis Study at Continental Clinical Solutions

BALTIMORE - June 9, 2015 - PRLog -- In a Community Diseases teleconference today, Saleh Stevens of Continental Clinical Solutions, announced that Continental is expanding the reach of its clinical research program.  In particular, Stevens noted that Continental's Neurology Department is now participating in a Multiple Sclerosis study that evidences the diversity that the company has in its neuro-research portfolio.  "We have always been a broad-based a research facility.  None of these areas are necessarily new to us. However, we are now comfortable going public in therapeutic areas like Multiple Sclerosis because our infrastructure supports it. Obviously, with diseases like MS, where we continue to look for cures, we need to expand the reach of clinical research. Stevens invites inquiries into its MS studies and Continental's growing clinical practice at http://www.continentalclinical.com/contact-us.html.

Continental Clinical Solutions is a dedicated clinical research facility based in Baltimore, Maryland.  Continental hosts and manages all aspects of industry sponsored clinical studies.